Evolution of Ebola Virus Disease from Exotic Infection to Global Health Priority, Liberia, Mid-2014
M. Allison Arwady, Kevin M. De Cock(Joint United Nations Programme on HIV/AIDS), Patrick Ayscue, Kurt E. Schaecher(Walter Reed National Military Medical Center), Bernice Dahn(Kennedy Memorial Hospital), Satish K. Pillai(University of California, San Francisco), Randal J. Schoepp(Centers for Disease Control and Prevention), Benjamin Monroe, Tolbert Nyenswah(National Public Health Institute of Liberia), Ilana J. Schafer, Lisa E. Hensley, Edward N. Rouse(Centers for Disease Control and Prevention), Tai-Ho Chen(Centers for Disease Control and Prevention), Almea Matanock, Luke Bawo(Ministry of Health and Social Welfare), Joseph D. Forrester, Thomas George(Centers for Disease Control and Prevention), Jennifer C. Hunter, Moses Massaquoi(Médecins Sans Frontières)
Cited by 52
Related Papers
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
|The Lancet|2008|2k
What is a resilient health system? Lessons from Ebola
|The Lancet|2015|802
The Lancet Commission on diagnostics: transforming access to diagnostics
|The Lancet|2021|442
Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo
|Nature Medicine|2024|350
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses
|Cell Reports Medicine|2021|219